Emerging Antifungal Targets and Strategies.

Marija Ivanov, Ana ��iri��, Dejan Stojkovi��
Author Information
  1. Marija Ivanov: Department of Plant Physiology, Institute for Biological Research "Sini��a Stankovi��"-National Institute of Republic of Serbia, University of Belgrade, Bulevar despota Stefana 142, 11000 Belgrade, Serbia. ORCID
  2. Ana ��iri��: Department of Plant Physiology, Institute for Biological Research "Sini��a Stankovi��"-National Institute of Republic of Serbia, University of Belgrade, Bulevar despota Stefana 142, 11000 Belgrade, Serbia. ORCID
  3. Dejan Stojkovi��: Department of Plant Physiology, Institute for Biological Research "Sini��a Stankovi��"-National Institute of Republic of Serbia, University of Belgrade, Bulevar despota Stefana 142, 11000 Belgrade, Serbia. ORCID

Abstract

Despite abundant research in the field of antifungal drug discovery, fungal infections remain a significant healthcare burden. There is an emerging need for the development of novel antifungals since those currently available are limited and do not completely provide safe and secure protection. Since the current knowledge regarding the physiology of fungal cells and the infection mechanisms is greater than ever, we have the opportunity to use this for the development of novel generations of antifungals. In this review, we selected and summarized recent studies describing agents employing different antifungal mechanisms. These mechanisms include interference with fungal resistance, including impact on the efflux pumps and heat shock protein 90. Additionally, interference with virulence factors, such as biofilms and hyphae; the impact on fungal enzymes, metabolism, mitochondria, and cell wall; and antifungal vaccines are explored. The agents investigated belong to different classes of natural or synthetic molecules with significant attention given also to plant extracts. The efficacy of these antifungals has been studied mainly in vitro with some in vivo, and clinical studies are needed. Nevertheless, there is a large quantity of products employing novel antifungal mechanisms that can be further explored for the development of new generation of antifungals.

Keywords

References

  1. Clin Microbiol Infect. 2019 Jul;25(7):792-798 [PMID: 30965100]
  2. J Biol Chem. 2008 Mar 7;283(10):6393-401 [PMID: 18165687]
  3. J Fungi (Basel). 2020 Jul 30;6(3): [PMID: 32751765]
  4. Mol Microbiol. 2002 Mar;43(5):1197-214 [PMID: 11918807]
  5. Org Lett. 2015 Feb 6;17(3):712-5 [PMID: 25622093]
  6. Infect Dis Ther. 2021 Mar;10(1):115-147 [PMID: 33523419]
  7. Curr Med Mycol. 2020;6(1):1-8 [PMID: 32420501]
  8. J Fungi (Basel). 2018 Apr 20;4(2): [PMID: 29677130]
  9. J Fungi (Basel). 2017;3(4): [PMID: 29333431]
  10. Dermatol Clin. 2007 Apr;25(2):165-83, vi [PMID: 17430754]
  11. FEMS Microbiol Lett. 2003 Jul 29;224(2):299-305 [PMID: 12892896]
  12. Arch Biochem Biophys. 2021 Mar 30;700:108772 [PMID: 33485850]
  13. Antibiotics (Basel). 2021 Jan 06;10(1): [PMID: 33419126]
  14. Virulence. 2016 Aug 17;7(6):649-59 [PMID: 27221657]
  15. Appl Microbiol Biotechnol. 2021 Mar;105(5):1953-1964 [PMID: 33576886]
  16. Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11156-9 [PMID: 22733749]
  17. J Antimicrob Chemother. 2019 Jul 1;74(7):1904-1910 [PMID: 31225606]
  18. Int J Mol Sci. 2021 Jan 06;22(2): [PMID: 33418931]
  19. Front Mol Biosci. 2021 Jan 12;7:621366 [PMID: 33511160]
  20. Antibiotics (Basel). 2020 Jul 25;9(8): [PMID: 32722455]
  21. Sci Rep. 2020 Jan 23;10(1):1066 [PMID: 31974431]
  22. Clin Dermatol. 2010 Mar 4;28(2):212-6 [PMID: 20347665]
  23. Ocul Surf. 2017 Oct;15(4):670-679 [PMID: 28602948]
  24. Drugs. 1998 May;55(5):645-74 [PMID: 9585862]
  25. Front Microbiol. 2021 May 20;12:658329 [PMID: 34093471]
  26. Antimicrob Agents Chemother. 2015 Jan;59(1):450-60 [PMID: 25385095]
  27. Open Forum Infect Dis. 2020 Jan 12;7(2):ofaa016 [PMID: 32099843]
  28. PLoS Pathog. 2019 Aug 5;15(8):e1007460 [PMID: 31381597]
  29. Med Microbiol Immunol. 2020 Feb;209(1):1-13 [PMID: 31555911]
  30. Clin Microbiol Infect. 2008 May;14 Suppl 4:25-36 [PMID: 18430127]
  31. ScientificWorldJournal. 2021 Sep 21;2021:8856147 [PMID: 34594161]
  32. J Cell Sci. 2002 Jan 15;115(Pt 2):293-302 [PMID: 11839781]
  33. mBio. 2017 Oct 3;8(5): [PMID: 28974618]
  34. Clin Transplant. 2016 Nov;30(11):1377-1386 [PMID: 27581783]
  35. Med Mycol. 2020 Jun 1;58(4):493-504 [PMID: 31297540]
  36. Colloids Surf B Biointerfaces. 2021 Apr;200:111617 [PMID: 33592455]
  37. Antimicrob Agents Chemother. 2020 Feb 21;64(3): [PMID: 31907188]
  38. Biotechnol Adv. 2019 Nov 1;37(6):107352 [PMID: 30797093]
  39. EXCLI J. 2020 Oct 29;19:1436-1445 [PMID: 33312106]
  40. Microorganisms. 2021 Feb 20;9(2): [PMID: 33672633]
  41. Front Microbiol. 2021 May 20;12:680382 [PMID: 34093502]
  42. Front Immunol. 2018 Apr 27;9:897 [PMID: 29755472]
  43. Microbes Infect. 2019 Jun - Jul;21(5-6):237-245 [PMID: 31255676]
  44. Appl Microbiol Biotechnol. 2005 Aug;68(2):151-62 [PMID: 15821914]
  45. Phytomedicine. 2021 Jul 15;88:153556 [PMID: 33958276]
  46. Pharmaceuticals (Basel). 2020 Apr 24;13(4): [PMID: 32344670]
  47. mSphere. 2019 Sep 4;4(5): [PMID: 31484737]
  48. Int J Mol Sci. 2020 Nov 06;21(21): [PMID: 33172206]
  49. J Proteomics. 2022 Jan 6;250:104385 [PMID: 34606990]
  50. Indian J Pharmacol. 2019 Mar-Apr;51(2):116-119 [PMID: 31142947]
  51. PLoS One. 2020 Nov 30;15(11):e0243066 [PMID: 33253287]
  52. Antimicrob Agents Chemother. 2017 Jul 25;61(8): [PMID: 28584159]
  53. Pharmacy (Basel). 2015 Oct 21;3(4):210-268 [PMID: 28975914]
  54. Appl Microbiol Biotechnol. 2021 Jan;105(1):55-66 [PMID: 33270153]
  55. Front Immunol. 2018 Jan 10;8:1968 [PMID: 29375581]
  56. J Med Microbiol. 2021 Mar;70(3): [PMID: 33599604]
  57. J Enzyme Inhib Med Chem. 2016;31(2):219-28 [PMID: 25815669]
  58. Pediatr Clin North Am. 2011 Feb;58(1):11-9, ix [PMID: 21281845]
  59. Biochem Biophys Res Commun. 2018 Jan 1;495(1):560-566 [PMID: 29129690]
  60. Biochem Pharmacol. 2017 Jun 1;133:86-96 [PMID: 27884742]
  61. Front Cell Infect Microbiol. 2021 Sep 03;11:713092 [PMID: 34540717]
  62. Int J Mol Sci. 2020 Apr 22;21(8): [PMID: 32331447]
  63. Pharmaceuticals (Basel). 2020 Dec 30;14(1): [PMID: 33396973]
  64. Antimicrob Agents Chemother. 2015 Apr;59(4):2153-68 [PMID: 25645848]
  65. Front Microbiol. 2020 Oct 23;11:561298 [PMID: 33193145]
  66. Future Med Chem. 2016 Aug;8(12):1485-501 [PMID: 27463566]
  67. Nat Chem Biol. 2014 May;10(5):400-6 [PMID: 24681535]
  68. Microbiol Res. 2015 Oct;179:20-8 [PMID: 26411891]
  69. Sci Rep. 2020 Sep 3;10(1):14575 [PMID: 32884060]
  70. Nat Commun. 2021 Jun 8;12(1):3418 [PMID: 34103502]
  71. Sci Rep. 2018 Dec 4;8(1):17570 [PMID: 30514888]
  72. J Cutan Med Surg. 2015 Jul-Aug;19(4):352-7 [PMID: 25775613]
  73. Emerg Infect Dis. 2019 Jan;25(1):176-178 [PMID: 30561296]
  74. J Chem Inf Model. 2011 Feb 28;51(2):455-62 [PMID: 21229992]
  75. Sci Bull (Beijing). 2021 Sep 30;66(18):1895-1905 [PMID: 36654399]
  76. Toxicol Appl Pharmacol. 2017 May 1;322:104-112 [PMID: 28286116]
  77. J Appl Microbiol. 2014 Sep;117(3):611-7 [PMID: 24863842]
  78. Front Microbiol. 2020 Jul 02;11:1498 [PMID: 32714312]
  79. Sci Rep. 2018 Jan 10;8(1):326 [PMID: 29321629]
  80. Molecules. 2021 Aug 18;26(16): [PMID: 34443595]
  81. Nat Commun. 2019 Jan 24;10(1):402 [PMID: 30679438]
  82. Front Microbiol. 2017 Aug 03;8:1476 [PMID: 28824600]
  83. Eur J Med Chem. 2022 Jan 5;227:113950 [PMID: 34731761]
  84. Virulence. 2017 Feb 17;8(2):159-168 [PMID: 27191707]
  85. ACS Infect Dis. 2015 Jan 9;1(1):59-72 [PMID: 26878058]
  86. Biomed Res Int. 2018 Nov 26;2018:4651726 [PMID: 30598996]
  87. BMC Infect Dis. 2017 Dec 28;17(1):798 [PMID: 29281997]
  88. Sci Rep. 2017 Jul 18;7(1):5692 [PMID: 28720834]
  89. J Fungi (Basel). 2021 Feb 25;7(3): [PMID: 33668824]
  90. PLoS Pathog. 2021 Apr 22;17(4):e1009470 [PMID: 33886695]
  91. Expert Opin Pharmacother. 2000 Jan;1(2):287-304 [PMID: 11249550]
  92. Drugs. 2001;61 Suppl 1:27-37 [PMID: 11219548]
  93. Front Microbiol. 2019 May 14;10:1085 [PMID: 31156594]
  94. Curr Med Chem. 2019;26(14):2536-2554 [PMID: 29956609]
  95. Int J Mol Sci. 2021 Apr 01;22(7): [PMID: 33915930]
  96. Plants (Basel). 2021 Nov 19;10(11): [PMID: 34834886]
  97. J Fungi (Basel). 2020 Oct 30;6(4): [PMID: 33143248]
  98. World J Microbiol Biotechnol. 2018 Oct 31;34(11):167 [PMID: 30382403]
  99. Pediatr Rev. 2006 Apr;27(4):158-9 [PMID: 16581959]
  100. J Mycol Med. 2022 Mar;32(1):101206 [PMID: 34624594]
  101. Gastroenterol Hepatol. 2019 Jun - Jul;42(6):394-395 [PMID: 31167724]
  102. Biomed Res Int. 2013;2013:204237 [PMID: 23878798]
  103. J Infect Dis. 2017 Aug 15;216(suppl_3):S474-S483 [PMID: 28911042]
  104. Expert Rev Anti Infect Ther. 2006 Apr;4(2):171-5 [PMID: 16597199]
  105. Front Bioeng Biotechnol. 2021 Oct 21;9:761518 [PMID: 34746111]
  106. NPJ Vaccines. 2021 Mar 3;6(1):33 [PMID: 33658522]
  107. J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):782-5 [PMID: 2229523]
  108. PLoS Pathog. 2008 Jul 18;4(7):e1000105 [PMID: 18636113]
  109. Pharm Biol. 2016;54(6):984-92 [PMID: 26459663]
  110. Cell Physiol Biochem. 2016;40(3-4):727-742 [PMID: 27915337]
  111. J Fungi (Basel). 2017 Mar;3(1): [PMID: 28516088]
  112. Evid Based Complement Alternat Med. 2021 Jul 22;2021:9961089 [PMID: 34335850]
  113. World J Microbiol Biotechnol. 2017 Mar;33(3):55 [PMID: 28224386]
  114. mSphere. 2020 Jan 8;5(1): [PMID: 31915228]
  115. BMC Microbiol. 2020 Feb 7;20(1):28 [PMID: 32028887]
  116. J Fungi (Basel). 2017 Feb 21;3(1): [PMID: 29371527]
  117. Sci Rep. 2021 Oct 26;11(1):21049 [PMID: 34702898]
  118. Amino Acids. 2021 Jul;53(7):961-991 [PMID: 34081205]
  119. Infect Immun. 2020 Sep 18;88(10): [PMID: 32661125]
  120. Sci Rep. 2016 Mar 31;6:23575 [PMID: 27030404]
  121. Antimicrob Agents Chemother. 2021 Jan 20;65(2): [PMID: 33229427]
  122. Antimicrob Agents Chemother. 2019 Jul 25;63(8): [PMID: 31182539]
  123. Front Med (Lausanne). 2016 Mar 15;3:11 [PMID: 27014694]
  124. J Chem Inf Model. 2017 Jun 26;57(6):1426-1438 [PMID: 28475320]
  125. Arch Pharm (Weinheim). 2020 Oct;353(10):e2000133 [PMID: 32638423]
  126. Front Microbiol. 2020 Feb 06;10:3114 [PMID: 32117083]
  127. Otolaryngol Clin North Am. 2000 Apr;33(2):237-49 [PMID: 10736402]
  128. Front Microbiol. 2020 May 08;11:864 [PMID: 32457728]
  129. PLoS Pathog. 2011 Sep;7(9):e1002257 [PMID: 21931556]
  130. Front Immunol. 2021 May 18;12:670578 [PMID: 34084170]
  131. Drug Des Devel Ther. 2016 Mar 16;10:1161-71 [PMID: 27042008]
  132. Microbiol Spectr. 2015 Jun;3(3): [PMID: 26397003]
  133. Virulence. 2019 Dec;10(1):490-501 [PMID: 31119976]
  134. J Chem Biol. 2014 Aug 27;7(4):143-61 [PMID: 25320648]
  135. Int J Mol Sci. 2017 Aug 25;18(9): [PMID: 28841152]
  136. Molecules. 2016 Jun 11;21(6): [PMID: 27294909]
  137. Trends Pharmacol Sci. 2022 Jan;43(1):69-79 [PMID: 34756759]
  138. Br J Dermatol. 1999 Jun;140(6):1196-7 [PMID: 10354111]
  139. Front Microbiol. 2013 Jan 10;3:439 [PMID: 23335918]
  140. Yeast. 2017 Jun;34(6):253-265 [PMID: 28181315]
  141. Drugs. 2016 Mar;76(4):485-500 [PMID: 26818726]
  142. Antibiotics (Basel). 2020 Dec 08;9(12): [PMID: 33302565]
  143. J Fungi (Basel). 2020 Oct 22;6(4): [PMID: 33105672]
  144. mBio. 2019 Nov 26;10(6): [PMID: 31772051]
  145. Med Mycol. 2021 Dec 03;59(12):1225-1237 [PMID: 34558629]

Grants

  1. 451-03-9/2021-14/200007/Ministarstvo prosvete, nauke i tehnoloskog razvoja

MeSH Term

Antifungal Agents
Biofilms
Cell Wall
Drug Resistance, Fungal
Humans
Hyphae
Mycoses

Chemicals

Antifungal Agents

Word Cloud

Created with Highcharts 10.0.0antifungalfungalantifungalsmechanismsdevelopmentnoveldrugdiscoverysignificantstudiesagentsemployingdifferentinterferenceresistanceimpactexploredDespiteabundantresearchfieldinfectionsremainhealthcareburdenemergingneedsincecurrentlyavailablelimitedcompletelyprovidesafesecureprotectionSincecurrentknowledgeregardingphysiologycellsinfectiongreatereveropportunityusegenerationsreviewselectedsummarizedrecentdescribingincludeincludingeffluxpumpsheatshockprotein90AdditionallyvirulencefactorsbiofilmshyphaeenzymesmetabolismmitochondriacellwallvaccinesinvestigatedbelongclassesnaturalsyntheticmoleculesattentiongivenalsoplantextractsefficacystudiedmainlyvitrovivoclinicalneededNeverthelesslargequantityproductscannewgenerationEmergingAntifungalTargetsStrategiesAspregillusCandidaantibiofilmtargetsmechanismactionmitochondrialactivity

Similar Articles

Cited By (37)